腫瘍アブレーションの世界市場予測(~2021年):ラジオ波アブレーション、マイクロ波アブレーション、冷凍アブレーション、IREアブレーション、超音波アブレーション、レーザアブレーション

◆英語タイトル:Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound, Laser), Mode of Treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021
◆商品コード:MAM-MD-3271
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2016年10月5日
◆ページ数:261
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥644,100見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、腫瘍アブレーションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、治療別分析、用途別分析、地域別分析、腫瘍アブレーションの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global tumor ablation market is expected to reach a value of USD 580.1 Million by 2021, at a CAGR of 12.5% during 2016-2021. A number of factors such as technological advancements in the field of tumor ablation focused on enhancing effectiveness and safety of the treatment, rising demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, and growing public-private initiatives and funding to support R&D activities in tumor ablation are propelling the growth of the market. However, factors such as unfavorable regulatory policies and cost-containment measures adopted by various governments are restraining the optimal market growth.
On the basis of technology, the global tumor ablation market is divided into four major categories, namely, radiofrequency ablation, microwave ablation, cryoablation, and others (includes electrical, laser/light, ultrasound). Based on mode of treatment, the market is segmented into surgical mode, laparoscopic mode, and percutaneous mode. On the basis of application of tumor ablation, the market is categorized into liver cancer, lung cancer, kidney/renal cancer, bone metastasis, and others (includes tumor ablation for the treatment of prostate, breast, colorectal, thyroid, pancreas, neuroendocrine, head, neck, and lumbar-vertebra cancer). In 2016, the radiofrequency ablation technology is estimated to dominate the market due its high demand for tumor ablation. The microwave ablation technology is estimated to register high growth due to its additional therapeutic benefits such as faster heat-generation (which reduces the susceptibility to damage to surrounding organs and gives opportunity to ablate larger tumors), lower heat-sink effect (that results in destruction of surrounding healthy tissue), and better safety & efficacy profile.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is estimated to dominate the global tumor ablation market. The rising prevalence and incidence of major types of cancer (such as liver, lung, kidney, and bone metastasis), rising inclination of patients towards minimally invasive procedures for cancer treatment, and increasing government funding for cancer research are driving the growth of the market in North America. The Asia-Pacific market is expected to register the highest CAGR from 2016 to 2021. This is primarily due to the rising prevalence of various cancers coupled with growing geriatric population, rising market demand of minimally invasive surgical procedures, growing medical tourism, and ongoing initiatives by various governments for the modernization of healthcare infrastructure in the region.

New product launches and product enhancements are the key growth strategies adopted by major players to enhance their positions in the global tumor ablation market. Additionally, strategic acquisitions along with geographic expansions; and partnerships, agreements, and collaborations were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the global market.

As of 2015, Angiodynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.) and Sonacare Medical, LLC (U.S.) were key players operating in the global market.

【レポートの目次】

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Limitations
1.5 Market Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Executive Summary
3.1 Introduction
3.2 History, Evolution, and Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 Market, By Technology
5.2.2 Market, By Mode of Treatment
5.3.3 Market, By Application
5.3 Market Evolution
5.4 Market Dynamics
5.4.1 Key Market Drivers
5.4.1.1 Growing Geriatric Population Across the World
5.4.1.2 Increasing Population Base for Cancer Patients
5.4.1.3 Technological Advancements in Ablation Devices
5.4.1.4 Sprouting Number of Hospitals, Surgical, and Ablation Centers
5.4.2 Key Market Restraints
5.4.2.1 Cost Containment Measures Taken By Various Governments
5.4.2.2 Ongoing Healthcare Reforms in the U.S.
5.4.3 Key Market Opportunities
5.4.3.1 Growth Potential Offered By Emerging Markets
5.4.3.2 Growing Awareness About Ablation Procedures Over Conventional Therapeutic and Surgical Procedures
5.4.4 Key Market Challenges
5.4.4.1 Stringent Regulatory Guidelines Leading to Significant Increase in Gestation Period of Product Launches

6 Industry Insights
6.1 Introduction
6.2 Value Chain Analysis
6.3 Industry Trends
6.3.1 Growing Adoption Rate of Radiofrequency-Based Tumor Ablation Procedures
6.3.2 Microwave Technology to Be the Fastest Growing Segment in Overall Tumor Ablation Businesses
6.4 Porter’s Five Forces Analysis
6.4.1 Threat From New Entrants
6.4.2 Threat From Substitutes
6.4.3 Bargaining Power of Suppliers
6.4.4 Bargaining Power of Buyers
6.4.5 Intensity of Competitive Rivalry

7 Tumor Ablation Market, By Technology
7.1 Introduction
7.2 Radiofrequency (RF) Ablation
7.3 Microwave Ablation
7.4 Cryoablation
7.5 Other Technologies*

8 Tumor Ablation Market, By Mode of Treatment
8.1 Introduction
8.2 Surgical Ablation
8.3 Laparoscopic Ablation
8.4 Percutaneous Ablation

9 Tumor Ablation Market, By Application
9.1 Introduction
9.2 Liver Cancer
9.3 Lung Cancer
9.4 Kidney Cancer
9.5 Bone Metastasis
9.6 Others**

10 Tumor Ablation Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Italy
10.3.2 Germany
10.3.3 France
10.3.4 U.K.
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World (RoW)

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis, By Key Players
11.3 Competitive Scenario
11.4 Recent Developments
11.4.1 New Products Launches and Product Enhancements
11.4.2 Agreements, Partnerships, and Agreements
11.4.3 Mergers and Acquisitions
11.4.4 Geographic Expansions
11.4.5 Other Developments

12 Compny Profiles
12.1 Introduction
12.1.1 Geographic Benchmarking
12.1.2 Strategic Benchmarking
12.2 Medtronic, PLC.
12.2.1 Company Overview
12.2.2 MnM Overview
12.2.3 Medtronic, PLC: Company Snapshot
12.2.4 Product Portfolio
12.2.5 Recent Developments (2014-2015)
12.3 Angiodynamics, Inc.
12.3.1 Company Overview
12.3.2 MnM Overview
12.3.3 Angiodynamics, Inc.: Company Snapshot
12.3.4 Product Portfolio
12.3.5 Recent Developments (2014-2015)
12.4 Healthtronics, Inc.
12.4.1 Company Overview
12.4.2 MnM Overview
12.4.3 Boston Scientific Corporation: Company Snapshot
12.4.4 Product Portfolio
12.4.5 Recent Developments (2014-2015)
12.5 Galil Medical, Inc.
12.5.1 Company Overview
12.5.2 MnM Overview
12.5.3 Endo International PLC: Company Snapshot
12.5.4 Product Portfolio
12.5.5 Recent Developments (2014-2015)
12.6 Boston Scientific Corporation
12.6.1 Company Overview
12.6.2 MnM Overview
12.6.3 Product Portfolio
12.6.4 Recent Developments (2014-2015)
12.7 Neuwave Medical, Inc.
12.7.1 Company Overview
12.7.3 Edap Tms S.A.: Company Snapshot
12.7.4 Product Portfolio
12.7.5 Recent Developments (2014-2015)
12.8 Edap Tms S.A.
12.8.1 Company Overview
12.8.2 Product Portfolio
12.8.3 Recent Developments (2014-2015)
12.9 Mermaid Medical A/S
12.9.1 Company Overview
12.9.2 Product Portfolio
12.9.3 Recent Developments (2014-2015)
12.10 Sonacare Medical, LLC
12.10.1 Company Overview
12.10.2 Misonix, Inc.: Company Snapshot
12.10.3 Product Portfolio
12.10.4 Recent Developments (2014-2015)
12.11 Misonix, Inc.
12.11.1 Company Overview
12.11.2 Product Portfolio
12.11.3 Recent Developments (2014-2015)

13 Appendix
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Introducing RT: Real Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports

List of Tables (72 Tables)

Table 1 Global Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 2 Market Size for Radiofrequency Ablation Technologies, By Region, 2014-2021 (USD Million)
Table 3 Market Size for Microwave Ablation Technology, By Region, 2014-2021 (USD Million)
Table 4 Market Size for Cryoablation Technology, By Region, 2014-2021 (USD Million)
Table 5 Market Size for Other Technologies, By Region, 2014-2021 (USD Million)
Table 6 Global Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 7 Market Size for Surgical Ablation Treatment, By Region, 2014-2021 (USD Million)
Table 8 Market Size for Laparoscopic Ablation Treatment, By Region, 2014-2021 (USD Million)
Table 9 Market Size for Percutaneous Ablation Treatment, By Region, 2014-2021 (USD Million)
Table 10 Global Market Size, By Application, 2014-2021 (USD Million)
Table 11 Market Size for Liver Cancer Ablation, By Region, 2014-2021 (USD Million)
Table 12 Market Size for Lung Cancer Ablation, By Region, 2014-2021 (USD Million)
Table 13 Market Size for Kidney Cancer Ablation, By Region, 2014-2021 (USD Million)
Table 14 Market Size for Bone Metastasis Ablation, By Region, 2014-2021 (USD Million)
Table 15 Market Size for Other Applications, By Region, 2014-2021 (USD Million)
Table 16 Market Size, By Region, 2014-2021 (USD Million)
Table 17 North American Market Size, By Country, 2014-2021 (USD Million)
Table 18 North American Market Size, By Technology, 2014-2021 (USD Million)
Table 19 North American Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 20 North American Market Size, By Application, 2014-2021 (USD Million)
Table 21 U.S.: Market Size, By Technology, 2014-2021 (USD Million)
Table 22 U.S.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 23 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 24 Canada: Market Size, By Technology, 2014-2021 (USD Million)
Table 25 Canada: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 26 Canada: Market Size, By Application, 2014-2021 (USD Million)
Table 27 European Market Size, By Country, 2014-2021 (USD Million)
Table 28 European Market Size, By Technology, 2014-2021 (USD Million)
Table 29 European Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 30 European Market Size, By Application, 2014-2021 (USD Million)
Table 31 Italy: Market Size, By Technology, 2014-2021 (USD Million)
Table 32 Italy: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 33 Italy: Market Size, By Application, 2014-2021 (USD Million)
Table 34 Germany: Market Size, By Technology, 2014-2021 (USD Million)
Table 35 Germany: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 36 Germany: Market Size, By Application, 2014-2021 (USD Million)
Table 37 France: Market Size, By Technology, 2014-2021 (USD Million)
Table 38 France: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 39 France: Market Size, By Application, 2014-2021 (USD Million)
Table 40 U.K.: Market Size, By Technology, 2014-2021 (USD Million)
Table 41 U.K.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 42 U.K.: Market Size, By Application, 2014-2021 (USD Million)
Table 43 Spain: Market Size, By Technology, 2014-2021 (USD Million)
Table 44 Spain: Market Size, By Mode of Treatment, 2014-2021 (USD Million
Table 45 Spain: Market Size, By Application, 2014-2021 (USD Million)
Table 46 Rest of Europe: Market Size, By Technology, 2014-2021 (USD Million)
Table 47 Rest of Europe: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 48 Rest of Europe: Market Size, By Application, 2014-2021 (USD Million)
Table 49 Asia-Pacific Market Size, By Country, 2014-2021 (USD Million)
Table 50 Asia-Pacific Market Size, By Technology, 2014-2021 (USD Million)
Table 51 Asia-Pacific Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 52 Asia-Pacific Market Size, By Application, 2014-2021 (USD Million)
Table 53 Japan: Market Size, By Technology, 2014-2021 (USD Million)
Table 54 Japan: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 55 Japan: Market Size, By Application, 2014-2021 (USD Million)
Table 56 China: Market Size, By Technology, 2014-2021 (USD Million)
Table 57 China: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 58 China: Market Size, By Application, 2014-2021 (USD Million)
Table 59 India: Market Size, By Technology, 2014-2021 (USD Million)
Table 60 India: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 61 India: Market Size, By Application, 2014-2021 (USD Million)
Table 62 Rest of Asia-Pacific: Market Size, By Technology, 2014-2021 (USD Million)
Table 63 Rest of Asia-Pacific: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 64 Rest of Asia-Pacific: Market Size, By Application, 2014-2021 (USD Million)
Table 65 RoW: Market Size, By Technology, 2014-2021 (USD Million)
Table 66 RoW: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 67 RoW: Market Size, By Application, 2014-2021 (USD Million)
Table 68 Top 5 New Product Launches and Product Enhancements, 2013–2016
Table 69 Top 5 Agreements, Partnerships, and Collaborations, 2013–2016
Table 70 Top 5 Geographical Expansions, 2013–2016
Table 71 Top 5 Mergers and Acquisitions, 2013–2016
Table 72 Top 5 Other Developments, 2013–2016


List of Figures (86 Figures)

Figure 1 Research Design
Figure 2 Data Triangulation
Figure 3 North America to Hold Largest Share of Market During the Forecast Period
Figure 4 RF Ablation to Lead the Revenue Growth of Tumor Ablation Technology Market During 2016-2021
Figure 5 Microwave Ablation Technology to Grow at Fastest CAGR During Study Period
Figure 6 North America to Dominate Surgical Tumor Ablation Treatment Market Till 2021
Figure 7 Liver Cancer to Lead Tumor Ablation Application Market During Forecast Period
Figure 8 Rise in Target Patient Population to Propel the Market Growth of Liver Cancer Ablation in APAC
Figure 9 Increasing Geriatric Population Across Key Mature and Emerging Nations
Figure 10 Worldwide Prevalence of Cancer – Expected Trend Till 2020
Figure 11 Market, By Technology: Expected Trend During 2016-2021
Figure 12 Market Share: RF Ablation Technology Market, By Region (2016)
Figure 13 Market Share: Microwave Ablation Technology Market, By Region (2016)
Figure 14 Market Share: Cryoablation Technology Market, By Region (2065)
Figure 15 Market Share: Other Ablation Technologies Market, By Region (2016)
Figure 16 Market, By Mode of Treatment: Expected Trend During 2016-2021
Figure 17 Market Share: Surgical Ablation Treatment Market, By Region (2016)
Figure 18 Market Share: Laparoscopic Ablation Treatment Market, By Region (2016)
Figure 19 Market Share: Percutaneous Ablation Treatment Market, By Region (2016)
Figure 20 Market, By Application: Expected Trend During 2016-2021
Figure 21 Market Share: Liver Cancer Ablation Market, By Region (2016)
Figure 22 Market Share: Lung Cancer Ablation Market, By Region (2016)
Figure 23 Market Share: Kidney Cancer Ablation Market, By Region (2016)
Figure 24 Market Share: Bone Metastasis Ablation Market, By Region (2016)
Figure 25 Market Share: Other Applications Market, By Region (2016)
Figure 26 Key Market Drivers for Global Market (2016-2021)
Figure 27 North America: Market, Expected Trend (2016 vs 2021)
Figure 28 North America: Market Share, By Technology, 2016
Figure 29 U.S.: Key Market Drivers for Market (2016-2021)
Figure 30 U.S.: Market Share, By Technology (2016)
Figure 31 U.S.: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 32 U.S.: Tumor Ablation Market Share, By Application (2016)
Figure 33 Canada: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 34 Canada: Tumor Ablation Market Share, By Technology (2016)
Figure 35 Canada: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 36 Canada: Tumor Ablation Market Share, By Application (2016)
Figure 37 Europe: Tumor Ablation Market, Expected Trend (2016 vs 2021)
Figure 38 Eu-5: Tumor Ablation Market Share, By Technology, 2016
Figure 39 Italy: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 40 Italy: Tumor Ablation Market Share, By Technology (2016)
Figure 41 Italy: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 42 Italy: Tumor Ablation Market Share, By Application (2016)
Figure 43 Germany: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 44 Germany: Tumor Ablation Market Share, By Technology (2016)
Figure 45 Germany: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 46 Germany: Tumor Ablation Market Share, By Application (2016)
Figure 47 France: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 48 France: Tumor Ablation Market Share, By Technology (2016)
Figure 49 France: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 50 France: Tumor Ablation Market Share, By Application (2016)
Figure 51 U.K.: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 52 U.K.: Tumor Ablation Market Share, By Technology (2016)
Figure 53 U.K.: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 54 U.K.: Tumor Ablation Market Share, By Application (2016)
Figure 55 Spain: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 56 Spain: Tumor Ablation Market Share, By Technology (2016)
Figure 57 Spain: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 58 Spain: Tumor Ablation Market Share, By Application (2016)
Figure 59 RoE: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 60 RoE: Tumor Ablation Market Share, By Technology (2016)
Figure 61 RoE: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 62 RoE: Tumor Ablation Market Share, By Application (2016)
Figure 63 Asia-Pacific: Tumor Ablation Market, Expected Trend (2016 vs 2021)
Figure 64 Asia-Pacific: Tumor Ablation Market Share, By Technology, 2016
Figure 65 Japan: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 66 Japan: Tumor Ablation Market Share, By Technology (2016)
Figure 67 Japan: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 68 Japan: Tumor Ablation Market Share, By Application (2016)
Figure 69 China: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 70 China: Tumor Ablation Market Share, By Technology (2016)
Figure 71 China: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 72 China: Tumor Ablation Market Share, By Application (2016)
Figure 73 India: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 74 India: Tumor Ablation Market Share, By Technology (2016)
Figure 75 India: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 76 India: Tumor Ablation Market Share, By Application (2016)
Figure 77 RoAPAC: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 78 RoAPAC: Tumor Ablation Market Share, By Technology (2016)
Figure 79 RoAPAC: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 80 RoAPAC: Tumor Ablation Market Share, By Application (2016)
Figure 81 RoW: Tumor Ablation Market, Expected Trend (2016 vs 2021)
Figure 82 RoW: Tumor Ablation Market Share, By Technology, 2016
Figure 83 Market Share Analysis: Medtronic, PLC to Lead Tumor Ablation Market Till 2021
Figure 84 Majority of Leading Players Focused on Product Development as Key Growth Strategy to Expand Their Market Share During Study Period
Figure 85 Top 4 Players Generated More Than 3/5th of Their Tumor Ablation Revenue From Americas
Figure 86 Technological Development and Product Enhancement is the Key Strategy Pursued By Top Players to Increase Their Tumor Ablation Market Revenue

【レポートのキーワード】

腫瘍アブレーション、腫瘍アブレーション技術、ラジオ波アブレーション、マイクロ波アブレーション、冷凍アブレーション、IREアブレーション、超音波アブレーション、レーザアブレーション、腫瘍切除術、アブレーション治療、不可逆性電気穿孔、手術、癌治療

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[腫瘍アブレーションの世界市場予測(~2021年):ラジオ波アブレーション、マイクロ波アブレーション、冷凍アブレーション、IREアブレーション、超音波アブレーション、レーザアブレーション]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月11日現在 219,328 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆